Edition:
United States

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

3.95USD
21 Sep 2018
Change (% chg)

$0.25 (+6.76%)
Prev Close
$3.70
Open
$3.75
Day's High
$3.95
Day's Low
$3.70
Volume
370,778
Avg. Vol
87,219
52-wk High
$5.75
52-wk Low
$1.58

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.82 -0.203
Mar '18 0.34 -0.228
FY 2017 Dec '17 0.74 0.480
Sep '17 1.49 -0.281
Jun '17 2.66 -0.288
Mar '17 3.11 -0.343
FY 2016 Dec '16 6.43 -0.214
Sep '16 3.37 -0.252
Jun '16 4.53 -0.245
Mar '16 3.03 -0.242
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 6 0.91 2.30 0.00 17.79
Quarter Ending Dec-18 6 5.96 20.32 0.00 12.59
Year Ending Dec-18 7 8.03 22.06 1.00 29.70
Year Ending Dec-19 7 18.33 30.60 5.26 67.89
Earnings (per share)
Quarter Ending Sep-18 7 -0.21 -0.18 -0.25 -0.05
Quarter Ending Dec-18 7 -0.17 0.07 -0.28 -0.17
Year Ending Dec-18 5 -0.83 -0.77 -0.86 -0.83
Year Ending Dec-19 7 -0.77 -0.58 -1.00 -0.29
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.45 32.71
P/E High - Last 5 Yrs. -- 279.26 47.27
P/E Low - Last 5 Yrs. -- 98.01 24.80
Beta 2.06 0.61 0.87
Price to Sales (TTM) 66.18 110.80 6.42
Price to Book (MRQ) -- 12.48 3.91
Price to Tangible Book (MRQ) -- 18.85 5.97
Price to Cash Flow (TTM) -- 62.31 23.27
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.69
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.62 -5.70
Payout Ratio(TTM) -- 5.94 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -69.24 179.03 8.45
Sales (TTM) vs TTM 1 Yr. Ago -78.24 93.99 6.71
Sales - 5 Yr. Growth Rate 27.27 24.50 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago 29.34 283.55 25.51
EPS (TTM) vs TTM 1 Yr. Ago 78.89 -- --
EPS - 5 Yr. Growth Rate -- 23.64 7.60
Capital Spending - 5 Yr. Growth Rate 23.83 38.63 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.96 1.64 2.20
Current Ratio (MRQ) 4.01 5.47 2.97
LT Debt to Equity (MRQ) -- 15.10 11.21
Total Debt to Equity (MRQ) -- 18.60 14.02
Interest Coverage (TTM) -2.95 -198.17 35.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -43.27 56.03 54.73
Gross Margin - 5 Yr. Avg. -- 52.71 53.30
EBITD Margin (TTM) -915.02 -- --
EBITD - 5 Yr. Avg -159.97 -176.77 15.89
Operating Margin (TTM) -947.17 -608.74 3.72
Operating Margin - 5 Yr. Avg. -170.05 -190.37 11.01
Pre-Tax Margin (TTM) -1,349.82 -605.96 4.04
Pre-Tax Margin - 5 Yr. Avg. -221.62 -192.95 11.19
Net Profit Margin (TTM) -322.55 -600.63 0.77
Net Profit Margin - 5 Yr. Avg. -178.66 -190.59 7.53
Effective Tax Rate (TTM) -- 11.58 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.15 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 82,634 5,333,198 715,149,750
Net Income/Employee (TTM) -266,537 -5,689,194 82,590,366
Receivable Turnover (TTM) 2.38 4.22 5.01
Inventory Turnover (TTM) 4.33 2.06 3.61
Asset Turnover (TTM) 0.05 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -15.30 0.77 9.73
Return on Assets - 5 Yr. Avg. -28.68 2.50 10.90
Return on Investment (TTM) -18.84 1.54 12.72
Return on Investment - 5 Yr. Avg. -32.46 1.99 14.02
Return on Equity (TTM) -- 0.30 14.84
Return on Equity - 5 Yr. Avg. -96.91 -2.37 15.37
  1 Year 3 Year 5 Year
Sales % -53.94 15.29 27.27
EPS (TTM) % 61.02 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AcelRx Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 9.65%
# of Holders: 70
Total Shares Held: 5,726,720
3 Mo. Net Change: -8,319,072
# New Positions: 16
# Closed Positions: 14
# Increased Positions: 35
# Reduced Positions: 24
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.